Skip to main navigation

menu

Vision and Leadership
Science and Pipeline
Commitment
Investors
- « Back
People
Contact

Vision and Leadership
Science and Pipeline
Commitment
Investors
- « Back
People
Contact

for investors

Cowen 42nd Annual Health Care Conference – Orphan Neuro and Neuromuscular Panel Discussion

Mar 7, 2022 9:10 AM EST

Click here for webcast

Site - Investor Relations - 2nd Tier

Overview
Stock Information
- Stock Quote
- Analyst Coverage
News & Events
- Press Releases
- Presentations & Events
Governance
- Governance
- Committee Composition
Financials
- SEC Filings
- Reports & Results
Investor Resources

Site - Investor Relations - 3rd Tier

Overview
Stock Information
- Stock Quote
- Analyst Coverage
News & Events
- Press Releases
- Presentations & Events
Governance
- Governance
- Committee Composition
Financials
- SEC Filings
- Reports & Results
Investor Resources

Press Releases

Press Releases

Year

Jan 03, 2022 Ovid Therapeutics Expands Epilepsy Franchise with Novel KCC2 Activators

Pagination

First page
Previous page
Page 1
Current page 2

Site - Stockholder Tools

Print Page RSS Feeds Share Page E-mail Alerts

Site - Footer Nav

Contact
Privacy Policy
Terms & Conditions Agreement
Community Guidelines
Third-Party Websites

Site - Footer - Social icons

Linkedin
Twitter
Webcast
Youtube
Facebook

© Copyright 2022 Ovid Therapeutics.

Ovid, Ovid Therapeutics, Ovid Therapeutics Inc., and BoldMedicine are trademarks of Ovid Therapeutics Inc. All rights reserved.

Site - Footer - Social icons

Linkedin
Twitter
Webcast
Youtube
Facebook

Share on:
Facebook
Twitter
LinkedIn
Reddit
Digg
Google
StumbleUpon
What's This?
Share this page through your favorite social channel or email this page to a colleague.